TY - JOUR T1 - Aromatase inhibitors in breast cancer: Current and evolving roles JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 561 LP - 567 VL - 69 IS - 7 AU - John Hill AU - Halle Moore Y1 - 2002/07/01 UR - http://www.ccjm.org/content/69/7/561.abstract N2 - The aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well. ER -